BACTERIOLOGICAL STUDY ON METHACYCLINE, A NEW TETRACYCLINE DERIVATIVE

Methacycline, a new tetracycline derivative, published by the study group of Pfizer Institute, U. S. A., is a broad spectrum antibiotic same as well-known tetracycline group antibiotic. How ever, it has 2∼4times antibacterial effect in vivo as compared with that of tetracycline and oxytetracyclite a...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 16; no. 1; pp. 90 - 92
Main Authors NISHINA, TAKESHI, YAMAMOTO, IKUO, NAKAZAWA, SHOZO, ITAGAKI, MORIMASA, MIYAGAWA, KAZUKO
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1968
Online AccessGet full text
ISSN0009-3165
1884-5894
DOI10.11250/chemotherapy1953.16.90

Cover

More Information
Summary:Methacycline, a new tetracycline derivative, published by the study group of Pfizer Institute, U. S. A., is a broad spectrum antibiotic same as well-known tetracycline group antibiotic. How ever, it has 2∼4times antibacterial effect in vivo as compared with that of tetracycline and oxytetracyclite and more prominent effect has also been observed in therapeutic experiment of mouse experimental infectious disease than in tetracycline and oxytetracycline as observed in vitro.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.16.90